Is Helen Sabzevari's PGEN share sale an open-market transaction?

The Form 4 lists the transaction as an open-market sale, but the footnote explains it was a sell-to-cover to pay tax withholding on vested restricted stock units, making it a tax-driven disposition rather than a discretionary sale.

Precigen (PGEN) CEO sells 119,250 shares in tax sell-to-cover transaction

Q: What insider transaction did PGEN CEO Helen Sabzevari report?

Helen Sabzevari reported a disposition of 119,250 shares of Precigen Common Stock. The shares were sold in a sell-to-cover transaction to meet tax withholding obligations linked to vesting restricted stock units.

Q: At what price were the PGEN shares sold in Helen Sabzevari's Form 4?

The reported shares were sold at $4.36 per share . This price applies to 119,250 shares of Precigen Common Stock sold in a sell-to-cover transaction related to tax withholding on vested restricted stock units.

Q: How many PGEN shares does Helen Sabzevari hold after this transaction?

After the reported sale, Helen Sabzevari directly holds 3,768,872 shares of Precigen Common Stock. This post-transaction balance reflects her remaining direct ownership following the 119,250-share sell-to-cover disposition.

Q: Why did PGEN CEO Helen Sabzevari sell 119,250 shares?

The 119,250 shares were sold in a sell-to-cover transaction to satisfy tax withholding obligations. These obligations arose upon the vesting of her restricted stock units on May 23, 2026, as described in the Form 4 footnote.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

PRECIGEN, INC. President and CEO Helen Sabzevari reported a disposition of company stock tied to tax obligations. She sold 119,250 shares of Common Stock at $4.36 per share in a sell-to-cover transaction to satisfy tax withholding upon the vesting of restricted stock units on May 23, 2026. Following this transaction, she directly holds 3,768,872 shares of Precigen common stock.

Insider Trade Summary

Net Seller: 119,250 shares ($519,930)

Net Sell 1 txn

Insider Sabzevari Helen

Role President and CEO

Sold 119,250 shs ($520K)

Type	Security	Shares	Price	Value
Sale	Common Stock	119,250	$4.36	$520K

Holdings After Transaction: Common Stock — 3,768,872 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Shares sold: 119,250 shares Sale price: $4.36 per share Shares owned after: 3,768,872 shares

3 metrics

Shares sold 119,250 shares Common Stock sold in sell-to-cover on May 28, 2026

Sale price $4.36 per share Price for Common Stock disposition

Shares owned after 3,768,872 shares Direct holdings following the reported transaction

Key Terms

sell-to-cover transaction, restricted stock units, tax withholding obligations, Common Stock

4 terms

sell-to-cover transaction financial

"sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations"

A sell-to-cover transaction is when a person granted company stock (for example as part of compensation or option exercise) immediately sells enough of those shares to pay required taxes or exercise costs and keeps the rest. Think of it like cashing part of a bonus to cover the tax bill; it provides necessary cash without the holder needing outside funds. Investors watch these sales because they increase trading volume and slightly reduce insider holdings, but they often reflect routine tax or cost management rather than a judgment on the company’s prospects.

restricted stock units financial

"tax withholding obligations upon the vesting of restricted stock units on May 23, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations"

Common Stock financial

"Represents the number of shares of Precigen common stock sold"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/01/2026 - 04:25 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sabzevari Helen

(Last)

(First)

(Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN

MARYLAND

20876

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/28/2026		S		119,250⁽¹⁾	D	$4.36	3,768,872	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents the number of shares of Precigen common stock sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations upon the vesting of restricted stock units on May 23, 2026.

	/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did PGEN CEO Helen Sabzevari report?

Helen Sabzevari reported a disposition of 119,250 shares of Precigen Common Stock. The shares were sold in a sell-to-cover transaction to meet tax withholding obligations linked to vesting restricted stock units.

At what price were the PGEN shares sold in Helen Sabzevari's Form 4?

The reported shares were sold at $4.36 per share. This price applies to 119,250 shares of Precigen Common Stock sold in a sell-to-cover transaction related to tax withholding on vested restricted stock units.

How many PGEN shares does Helen Sabzevari hold after this transaction?

After the reported sale, Helen Sabzevari directly holds 3,768,872 shares of Precigen Common Stock. This post-transaction balance reflects her remaining direct ownership following the 119,250-share sell-to-cover disposition.

Why did PGEN CEO Helen Sabzevari sell 119,250 shares?

The 119,250 shares were sold in a sell-to-cover transaction to satisfy tax withholding obligations. These obligations arose upon the vesting of her restricted stock units on May 23, 2026, as described in the Form 4 footnote.